APOTHEEK JUSTITIA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
APOTHEEK JUSTITIA
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€32,892
2024 · €16,285+€16,607
Equity
€364,123
2024 · €351,231+€12,892
Cash
€51,200
2024 · €50,449+€751
Balance sheet total
€445,020
2024 · €435,867+€9,153
Largest movements
Assets
- Stocks and contracts +€5,447
up €5,447 (+11.7%), from €46,454 to €51,901
Equity and liabilities
- Other debts +€20,020
new in 2025: €20,020
- Trade debts -€18,893
down €18,893 (-36.9%), from €51,148 to €32,254
- Profit (loss) carried forward +€12,892
up €12,892 (+14.3%), from €90,130 to €103,022
Income statement
- Gross operating margin +€15,966
up €15,966 (+50.7%), from €31,521 to €47,487
- Taxes -€927
down €927 (-16.5%), from €5,622 to €4,695
- Depreciation +€654
up €654 (+15.1%), from €4,327 to €4,980
- Other operating charges -€543
down €543 (-58.5%), from €929 to €386
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€16,285
Gross operating margin
+€15,966
Depreciation
-€654
Other operating charges
+€543
Financial income
+€1
Financial charges
-€175
Taxes
+€927
Result 2025
€32,892
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€31,416
Investment
-€5,883
Financing
-€24,782
Cash 2024
€50,449
From operations (derived)
+€31,416
Net result for the year
+€32,892
Depreciation
+€4,980
Stocks and contracts
-€5,447
Receivables within one year
-€2,734
Deferred charges and accrued income
+€682
Trade debts
-€18,893
Tax, wage and social debts
-€83
Other debts
+€20,020
Investment (derived)
-€5,883
Investment in fixed assets (net)
-€5,883
Financing
-€24,782
Debts after one year
-€4,106
Current portion of long-term debt
-€677
Contributions, distributions and other
-€20,000
Cash 2025
€51,200
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €435,867 | €445,020 | +€9,153 | +2.1% |
| Fixed assets | 21/28 | €20,251 | €21,154 | +€903 | +4.5% |
| Tangible fixed assets | 22/27 | €19,609 | €20,512 | +€903 | +4.6% |
| Plant, machinery and equipment | 23 | €5,992 | €9,020 | +€3,027 | +50.5% |
| Furniture and vehicles | 24 | €19 | - | -€19 | |
| Other tangible fixed assets | 26 | €13,598 | €11,493 | -€2,106 | -15.5% |
| Financial fixed assets | 28 | €642 | €642 | = | 0.0% |
| Current assets | 29/58 | €415,616 | €423,866 | +€8,250 | +2.0% |
| Stocks and contracts in progress | 3 | €46,454 | €51,901 | +€5,447 | +11.7% |
| Stocks | 30/36 | €46,454 | €51,901 | +€5,447 | +11.7% |
| Amounts receivable within one year | 40/41 | €309,507 | €312,240 | +€2,734 | +0.9% |
| Trade receivables | 40 | €31,890 | €28,484 | -€3,406 | -10.7% |
| Other amounts receivable | 41 | €277,616 | €283,756 | +€6,140 | +2.2% |
| Cash at bank and in hand | 54/58 | €50,449 | €51,200 | +€751 | +1.5% |
| Deferred charges and accrued income | 490/1 | €9,206 | €8,524 | -€682 | -7.4% |
| Total equity and liabilities | 10/49 | €435,867 | €445,020 | +€9,153 | +2.1% |
| Equity | 10/15 | €351,231 | €364,123 | +€12,892 | +3.7% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €242,501 | €242,501 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €240,641 | €240,641 | = | 0.0% |
| Profit (loss) carried forward | 14 | €90,130 | €103,022 | +€12,892 | +14.3% |
| Amounts payable | 17/49 | €84,635 | €80,896 | -€3,739 | -4.4% |
| Amounts payable after more than one year | 17 | €25,320 | €21,214 | -€4,106 | -16.2% |
| Financial debts | 170/4 | €25,320 | €21,214 | -€4,106 | -16.2% |
| Amounts payable within one year | 42/48 | €59,316 | €59,682 | +€367 | +0.6% |
| Current portion of amounts payable after more than one year | 42 | €6,474 | €5,797 | -€677 | -10.5% |
| Trade debts | 44 | €51,148 | €32,254 | -€18,893 | -36.9% |
| Suppliers | 440/4 | €51,148 | €32,254 | -€18,893 | -36.9% |
| Taxes, remuneration and social security | 45 | €1,694 | €1,611 | -€83 | -4.9% |
| Taxes | 450/3 | €1,694 | €1,611 | -€83 | -4.9% |
| Other amounts payable | 47/48 | - | €20,020 | +€20,020 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,327 | €4,980 | +€654 | +15.1% |
| Other operating charges | 640/8 | €929 | €386 | -€543 | -58.5% |
| Gross operating margin | 9900 | €31,521 | €47,487 | +€15,966 | +50.7% |
| Operating profit (loss) | 9901 | €26,265 | €42,121 | +€15,855 | +60.4% |
| Financial income | 75/76B | €10 | €11 | +€1 | +5.8% |
| Recurring financial income | 75 | €10 | €11 | +€1 | +5.8% |
| Financial charges | 65/66B | €4,369 | €4,545 | +€175 | +4.0% |
| Recurring financial charges | 65 | €4,369 | €4,545 | +€175 | +4.0% |
| Profit (loss) for the period before taxes | 9903 | €21,907 | €37,587 | +€15,680 | +71.6% |
| Income taxes | 67/77 | €5,622 | €4,695 | -€927 | -16.5% |
| Profit (loss) for the period | 9904 | €16,285 | €32,892 | +€16,607 | +102% |
| Profit (loss) for the period to be appropriated | 9905 | €16,285 | €32,892 | +€16,607 | +102% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.